Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Friday, October 9, 2026

Gait impairment characterization in hereditary spastic paraplegia using foot-mounted IMU sensors

 Does your doctor have ANY BRAINS AT ALL  to see that this could provide an objective gait analysis so protocols could be mapped to fix the problems? 

NO! So COMPLETELY FUCKING INCOMPETENT,  along with the hospital and board of directors!

Gait impairment characterization in hereditary spastic paraplegia using foot-mounted IMU sensors

Gait impairment characterization in hereditary spastic paraplegia using foot-mounted IMU sensors

    We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.

    Abstract

    Measurement of neurologic function is critical for diagnosis, prognosis, and clinical trials. Wearable inertial measurement units (IMUs) offer a compact and unobtrusive sensing method to capture spatio-temporal gait data in clinic and non-clinic environments. We used validated IMU-based algorithms to extract spatiotemporal and inertial gait features in 53 patients with Hereditary Spastic Paraplegia (HSP) (43 UHSP, 10 CHSP), drawn from a cohort of 69 enrolled subjects after excluding trials with incomplete or corrupted data. Classification models were trained to distinguish between uncomplicated (UHSP) and complicated (CHSP) diagnoses of HSP using two feature sets: i) a spatiotemporal (ST) feature set associated to stride length, width, duration, and speed, and ii) a spatiotemporal and inertial (STI) feature set associated with swing acceleration and angular velocity. STI features showed statistically significant differences between UHSP and CHSP patient cohorts and improved classification performance relative to classifiers trained with ST features alone: a linear support vector machine trained on STI features achieved 86.8% accuracy, 70.0% CHSP recall, and an AUC of 0.77 under leave-one-subject-out cross-validation, compared to 73.6% accuracy and an AUC of 0.65 for the same model trained on ST features only. These findings highlight the utility of wearable IMUs for detailed gait assessment and underscore the potential of STI features to capture gait impairment associated with HSP diagnostic subtype beyond what spatiotemporal metrics alone provide. Given the small, imbalanced complicated-HSP sample (n=10), these estimates carry wide confidence intervals and should be interpreted as preliminary. IMU-based approaches provide a scalable and portable tool for evaluating neurologic gait disorders that merits validation in larger cohorts.

    No comments:

    Post a Comment